The antihistamine and anxiolytic medication, hydroxyzine, is sometimes a consideration in the context of substance screening. This is due to the potential for confusion with other substances during the testing process. Understanding the interaction between this medication and the potential for a false positive is important.
The primary consideration lies in the accuracy and specificity of the drug screening methodologies employed. Certain immunoassay tests, which are commonly used for initial screening, might produce results that suggest the presence of substances that are not actually present. This can create complications in healthcare and employment settings.
